You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 166 No. 4, February 27, 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Women's Health
 •Menopause
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic

Decision Making at the Fringe of Evidence

Take What You Can Get

Arch Intern Med. 2006;166:389-390.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The symptoms of menopause can disrupt the lives of menopausal women by triggering menstrual irregularity, hot flashes, insomnia, and vaginal dryness. While the severity and duration of symptoms vary, most women seek some form of symptom relief.1 Menopausal hormone therapy (HT), the only highly effective treatment for menopausal symptoms, had been the mainstay of treatment until large randomized studies reported cardiovascular disease risks associated with its use and confirmed risks of breast cancer and venous thrombotic events.2 In the wake of these studies, many women have turned to natural remedies, with substantial growth in sales of phytoestrogens, herbal remedies, and bioidentical or "natural" hormones. The rising popularity of unproven, untested menopausal treatments demonstrates that many women find the risk-benefit profile of standard HT preparations to be unacceptable.

In this issue, Lemaitre et al3 compare 2 different HT formulations that are considered to be clinically interchangeable and biologically equivalent: esterified estrogens . . . [Full Text of this Article]


AUTHOR INFORMATION
Nananda F. Col, MD, MPP, MPH


RELATED ARTICLE

Esterified Estrogen and Conjugated Equine Estrogen and the Risk of Incident Myocardial Infarction and Stroke
Rozenn N. Lemaitre, Noel S. Weiss, Nicholas L. Smith, Bruce M. Psaty, Thomas Lumley, Eric B. Larson, and Susan R. Heckbert
Arch Intern Med. 2006;166(4):399-404.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.